Vanadyl ions binding to GroEL (HSP60) and inducing its depolymerization

Chinese Science Bulletin

Volumn 52, Issue 20, 2007, Pages 2775-2781

  Lei, Wanhua ^a   Liu, Huixue ^a   Zhong, Lijun ^a   Yang, Xiaoda ^a   Wang, Kui ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Diabetes; HSP60; Mitochondria; Vanadium

Indexed keywords

RATTUS;

EID: 35148890628     PISSN: 10016538     EISSN: 18619541     Source Type: Journal    
DOI: 10.1007/s11434-007-0380-0     Document Type: Article

References (44)

1. Willsky G R, Goldfine A B, Kostyniak P J, et al. Effect of vanadium (IV) compounds in the treatment of diabetes: in vivo and in vitro studies with vanadyl sulfate and bis(maltolato)oxovandium(IV). J Inorg Biochem, 2001, 85: 33-42
2. Heyliger C E, Tahiliani A G, McNeill J H. Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Science, 1985, 227(4693): 1474-1477
3. Evangelou A M. Vanadium in cancer treatment. Crit Rev Oncol/Hematol, 2002, 42: 249-265
4. Posner B I, Faure R, Burgess J W, et al. Peroxovanadium compounds. J Biol Chem, 1994, 269(6): 4596-4604
5. Huyer G, Liu S, Kellyi J, et al. Mechanism of inhibition of proteintyrosine phosphatases by vanadate and pervanada. J Biol Chem, 1997, 272(2): 843-851
6. Li J, Elberg G, Sekar N, et al. Antilipolytic actions of vanadate and insulin in rat adipocytes mediated by distinctly different mechanisms. Endocrinology, 1997, 138(6): 2274-2279
7. Anello M, Lupi R, Spampinato D, et al. Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients. Diabetologia, 2005, 48: 282-289
8. Petersen K F, Dufour S, Shulman G I. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents. PLos Med, 2005, 2(9): 0879-0884
9. Petersen K F, Dufour S, Befroy D, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med, 2004, 350(7): 664-671
10. Petersen K F, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science, 2003, 300: 1140-1142
11. Boirie Y. Insulin regulation of mitochondrial proteins and oxidative phosphorylation in human muscle. Trends Endocrinol Metab, 2003, 14(9): 393-394
12. Kelley D E, He J, Menshikova E V, et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes, 2002, 51: 2944-2950
13. Pollack M, Leeuwenburgh C. Apoptosis and aging: Role of the mitochondria. J Gerontol Ser A-Biol Sci Med Sci, 2001, 56A(11): B475-B482
14. Yang X, Yang X, Yuan L, et al. The permeability and cytotoxicity of insulin-mimetic vanadium compounds. Pharm Res, 2004, 21(6): 1026-1033
15. Susin S A, Larochette N, Geuskens M, et al. Purification of mitochondria for apoptosis assays. Methods Enzymol, 2000, 322: 205-208
16. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 1976, 72: 248-254
17. Zhang A M, Cui H, Qin Y H. Catalytic photometric determination of trace vanadium(V) using vanadium-potassium chlorate-dimethyl yellow system. Analytical Lab (in Chinese), 1994, 13(3): 44-51
18. Zhou T H. Manual of Analytical Chemistry (in Chinese). Beijing: Chemical Industry Press, 1997. 517
19. Penn N, Mackler B. Microsomal DPNH cytochrome c reductase. Biochim Biophys Acta, 1958, 27(3): 539-543
20. Wiley J. Current Protocols in Molecular Biology. New York: John Whiley & Sons, Inc, 1996
21. Xiao K, Shenoy S K, Nobles K, et al. Activation-dependent conformational changes in ta-arrestin 2. J Biol Chem, 2004, 279(53): 55744-55753
22. Verma S, Cam M C, McNeill J H. Nutritional factors that can favorably influence the glucose/insulin system: Vanadium. J Am Coll Nutr, 1998, 17(1): 11-18
23. Sakurai H, Tsuchiya K, Nukatsuka M, et al. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats. J Endocrinol, 1990, 126(3): 451-459
24. Heinemann G, Fichtl B, Mentler M, et al. Binding of vanadate to human albumin in infusion solutions, to proteins in human fresh frozen plasma, and to transferrin. J Inorg Biochem, 2002, 90: 38-42
25. Harris W R, Carrano C J. Binding of vanadate to human serum transferrin. J Inorg Biochem, 2001, 22(3): 201-218
26. Grady J K, Shao J L, Arosio P, et al. Vanadyl(IV) binding to mammalian ferritins: An EPR study aided by site-directed mutagenesis. J Inorg Biochem, 2000, 80: 107-113
27. Parra-Diaz D, Wei Q, Lee E Y C, et al. Binding of vanadium (IV) to the phosphatase calcineurin. FEBS Lett, 1995, 376: 58-60
28. 2+ cofactor. J Bioenerg Biomembr, 2000, 32(5): 539-546
29. 1-ATPase from chlamydomonas reveals changes in metal ligation resulting from mutations to the phosphate-binding loop threonine (bT168). J Biol Chem, 1999, 274(11): 7089-7094
30. Nechay B R, Nanninga L B, Nechay P S E. Vanadyl(IV) and vanadate(V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution. Arch Biochem Biophys, 1986, 251(1): 128-138
31. Scheffler N K, Miller S W, Carroll A K, et al. Two-dimensional electrophoresis and mass spectrometric identification of mitochondrial proteins from an SH-SY5Yneuroblastoma cell line. Mitochondrion, 2001, 1: 161-179
32. Xu Z H, Horwich A L, Sigler P B. The crystal structure of the asymmetric GroEL-GroES-(ADP)7 chaperonin complex. Nature, 1997, 388: 741-750
33. Chaudhry C, Farr G W, Todd M J, et al. Role of the γ-phosphate of ATP in triggering protein folding by GroEL-GroES: Function, structure and energetics. Embo J, 2003, 22(19): 4877-4887
34. Nadanaciva S, Weber J, Senior A E. Binding of the transition state analog MgADP-fluoroaluminate F1-ATPase. J Biol Chem, 1999, 274: 7052-7058
35. Park S, Ajtai K, Burghardt T P. Mechanism for coupling free energy in ATPase to the myosin active site. Biochemistry, 1997, 36: 3368-3372
36. Combeau C, Carlier M F. Probing the mechanism of ATP hydrolysis on F-actin using vanadate and the structural analogs of phosphate BeF3 and AlF4. J Biol Chem, 1988, 263: 17429-17436
37. Ramos S, Manuel M, Tiago T, et al. Decavanadate interactions with actin: Inhibition of G-actin polymerization and stabilization of decameric vanadate. J Inorg Biochem, 2006, 100(11): 1734-1743
38. Chen Z, Su W A, Tang Z C. Heat protective role and mechanism of heat shock protein Hpc60. Chin Sci Bull, 2000, 45(2): 161-164
39. Ostermann J, Horwich A L, Neupert W, et al. Protein folding in mitochondria requires complex formation with hsp60 and ATP hydrolysis. Nature, 1989, 341: 125-130
40. Soltys B J, Gupta R S. Immunoelectron microscopic localization of the 60-kDa heat shock chaperonin protein (Hsp60) in mammalian cells. Exp Cell Res, 1996, 222: 16-27
41. Gupta S, Knowlton A A. HSP60, bax, apoptosis and the heart. J Cell Mol Med, 2005, 9(1): 51-58
42. Brudzynski K, Cunninghamt I A, Martinez V. A family of hsp60-related proteins in pancreatic beta cells of non-obese diabetic (NOD) mice. J Autoimmun, 1995, 8: 859-874
43. Birk O S, Douek D C, Elias D, et al. A role of Hsp60 in autoimmune diabetes: Analysis in a transgenic model. Proc Natl Acad Sci U S A, 1996, 93(3): 1032-1037
44. Birk O S, Elias D, Weiss A S, et al. NOD mouse diabetes: The ubiquitous mouse Hsp60 is a β-cell target antigen of autoimmune T cells. J Autoimmun, 1996, 9: 159-166